Tcell

LeakSignal Announces Open-Source Mesh Runtime Security Platform to Secure Microservice Environments

Retrieved on: 
Tuesday, March 28, 2023
Data Management, Security, Technology, Software, Networks, Internet, Cloud, Instart, EBPF, IBM, Network, Tcell, Node.js, Web API security, Audit, Policy, API, Apigee, OpenShift, Cash, CSPM, Organization, Hales, Acquisition, Platform, Application, Data, Red Hat, Logic, Architecture, Entrepreneurship, Cryptocurrency, Video game, Engineering, Privacy

The Network and API security solutions on the market today were built for monolithic, Web 2.0 types of architecture and logic.

Key Points: 
  • The Network and API security solutions on the market today were built for monolithic, Web 2.0 types of architecture and logic.
  • As organizations transition to the next generation of Application Development & Platform technologies, these solutions don’t cater to the new insurgence of microservice and serverless environments.
  • Assessment: Empower security teams with risk severity views across all services, allowing strict compliance, frameworks, and security requirements to be attested & enforced.
  • “Digital-native companies already rely heavily on modern service mesh technologies, including sophisticated security at the edge,” said Manik Surtani, VP of Engineering, Platform and Cloud, CashApp, Block.

Finding HIV's Sweet Spot

Retrieved on: 
Tuesday, July 5, 2022
Cell, Memory, Wistar Institute, National, Media contacts database, Communication, University of California, San Francisco, Tcell, Roan, Protein, Tissue, AIDS, Biomarker, Infection, Population, UM1, Center, Blood, HIV, SAN, Bias, Fucose, CyTOF, Moore v. Regents of the University of California, Technology, University, Sugar, Antibody, Doctor of Philosophy, Virus, Urology, Cell biology, Gladstone Institutes, HIV/AIDS, Research, Severe acute respiratory syndrome coronavirus 2, HIV/AIDS research, Multimedia, Lectin, Collection, Vaccine, Pharmaceutical industry, Antibiotics, ELife, William Ewart Gladstone

SAN FRANCISCO, July 5, 2022 /PRNewswire/ -- HIV researchers have long been trying to identify the specific cells that the virus prefers to infect and hide in. They know that HIV favors a special type of immune cells called memory CD4 T cells. But these cells come in many flavors, and it has been difficult to ascertain exactly what makes one type of memory CD4 T cell more attractive to HIV than another.

Key Points: 
  • Together, the scientists uncovered surprisingly different sugar patterns on different immune cells, and an intriguing interplay between HIV and the sugars coating CD4 Tcells.
  • The work also showcases a new technique for studying individual cells from large populations that could lead to a more detailed picture of cellular diversity.
  • Encouraged by this finding, the scientists next applied CyTOF-Lec to CD4 Tcells that they had first exposed to HIV in the lab.
  • To ensure our work does the greatest good, Gladstone Institutes focuses on conditions with profound medical, economic, and social impactunsolved diseases.

Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer

Retrieved on: 
Wednesday, June 29, 2022
Tufts University School of Medicine, National, Health, View, Patient, Artax, Bureau of Oceans and International Environmental and Scientific Affairs, Medical Corps (United States Army), CEO, Liver transplantation, National Institute, MedStar Georgetown University Hospital, Walter Reed Army Medical Center, Therapure BioPharma Inc, Behavior, Immunosuppression, Medical Affairs Bureau, CTI, Company, Industry, TCR, Degenerative disease, NIH, CMO, Tcell, Immune system, National Institute of Diabetes and Digestive and Kidney Diseases, Risk, Lymphoma, Regulation, Kidney, NIDDK, University, Autoimmune disease, Digestive, Immunomodulation, Infection, Leadership, Lieutenant colonel, Children's Oncology Group, Bristol Myers Squibb, Multimedia, Organ, Transplant, Vaccine, Dentistry, NCK

CAMBRIDGE, Mass., June 29, 2022 /PRNewswire/ -- Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announces the appointment of D. Scott Batty, Jr., M.D. as Chief Medical Officer. Dr. Batty will direct the Company's scientific and clinical research programs, including Artax's ongoing Phase 1 clinical trial evaluating AX-158, the Company's first-in-class, oral small molecule immunomodulating agent that selectively modulates inappropriate T cell activation, a known cause of autoimmune disease. Importantly, AX-158 has the potential to treat T Cell-mediated diseases without the risk of immunosuppression.

Key Points: 
  • Prior to joining Artax, Dr. Batty was VP of Regulatory and Scientific Affairs for CTI, Inc., a privately held contract research organization.
  • Previous roles included Chief Medical Officer at Medeor Therapeutics, which developed an organ transplantation cell therapy platform to avoid the use of pharmacologic immunosuppression; Chief Executive Officer of ImmunArray Ltd., and Vice President of Global Medical Affairs for Genzyme Transplant and Oncology Group.
  • Dr. Batty was also a Global Director of Medical Affairs for the belatacept immunosuppression program while at Bristol-Myers Squibb.
  • Artax Biopharma is a clinical-stage biotechnology company transforming TCell-mediated disease treatment by developing innovative small molecules that modulate the immune system.

Global Single Cell Bioinformatics Software and Services Market to Reach $634.8 Million by 2031 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 23, 2022
Technology, Software, Name, Tcell, CAGR, Heart, R, Data analysis, RNA, Infection, COVID-19, Inflammation, Kidney, QIAGEN, Gene, Liver, Gene expression, Cancer, Research, BCR, Growth, Region, Services marketing, Prognosis, Investment, TCR, Illumina, Inc., Lists of diseases, Patient, Face, Mobile phone, Fine chemical, Vaccine

The global single cell bioinformatics software and services market was estimated to be at $205.2 million in 2020, which is expected to grow with a CAGR of 10.89% and reach $634.8 million by 2031.

Key Points: 
  • The global single cell bioinformatics software and services market was estimated to be at $205.2 million in 2020, which is expected to grow with a CAGR of 10.89% and reach $634.8 million by 2031.
  • The growth in the global single cell bioinformatics software and services market is expected to be driven by an increasing number of bioinformatics services being offered for computational analysis and a rising number of open-source free platform providers offering single cell analysis software.
  • The single cell bioinformatics software and services market is still in the nascent phase.
  • Increasing investments in the R&D of cell bioinformatics software and services and various research fundings is one of the major opportunities in the global cell bioinformatics software and services market.

Rapid7 Named a Visionary for Second Consecutive Year in Gartner® Magic Quadrant™ for Application Security Testing

Retrieved on: 
Thursday, April 21, 2022
Tcell, RPD, SAST, Magic Quadrant, Twitter, NASDAQ, Research, DevOps, API, Automation, Organization, GLOBE, Checkmarx, Blog, SDLC, LinkedIn, Technology, Application, SCA, Static application security testing, Infrastructure as code, Solution, Publication, RASP, Risk, Risk management, Software, Gartner, Metasploit Project

BOSTON, April 21, 2022 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leading provider of security analytics and automation, today announced it has been recognized as a Visionary by Gartner for the second consecutive year in the 2022 Magic Quadrant for Application Security Testing.

Key Points: 
  • BOSTON, April 21, 2022 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leading provider of security analytics and automation, today announced it has been recognized as a Visionary by Gartner for the second consecutive year in the 2022 Magic Quadrant for Application Security Testing.
  • Rapid7s best-in-class application security portfolio integrates with its broader security operations platform to seamlessly generate application security insights for key stakeholders across the software delivery lifecycle (SDLC) in order to quickly remediate vulnerabilities and reduce risk.
  • Rapid7 is well known for its expanding portfolio of solutions that deliver on modern application security requirements.
  • To view a complimentary copy of the full Gartner Magic Quadrant for Application Security Testing report, click here .

NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles

Retrieved on: 
Thursday, February 17, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Technology, Other Technology, Tcell, AI, Cancer, Immunotherapy, Allele, NOI, Technology, Neoplasm, Artificial intelligence, NEC, Software, Blood, Gaps, HLA, Organ transplantation, Library, Vaccine

NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy.

Key Points: 
  • NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy.
  • The computational approach performs HLA typing from next generation sequencing data by using the current strengths of conventional HLA typing while simultaneously allowing for the discovery of novel HLA alleles and tumor-specific HLA variants, through leveraging proprietary mutation calling bioinformatics at NOI.
  • NOI collaborated with Ultimovacs ASA in the study to validate the HLA typing approach from the blood of numerous donors using deep targeted HLA sequencing.
  • The validation confirmed almost 100% of HLA typing success at the 1st and 2nd fields of resolution.

Turkcell’s Hello Hope Provides Refugees With COVID-19 Information

Retrieved on: 
Wednesday, September 9, 2020
Mobile, Wireless, Technology, Telecommunications, Software, Philanthropy, Family, Internet, Consumer, Data management, Other Philanthropy, European migrant crisis, Refugees of the Syrian Civil War, Syrian Civil War, Syrian diaspora, Turkish Red Crescent, Tcell, TKC, Turkcell, Companies, Countries, Organizations

Hello Hope, a mobile application launched after the initial influx fleeing Syria by Turkcell (NYSE:TKC) (BIST:TCELL), provides refugees with information about the coronavirus pandemic through collaborations with international and national institutions.

Key Points: 
  • Hello Hope, a mobile application launched after the initial influx fleeing Syria by Turkcell (NYSE:TKC) (BIST:TCELL), provides refugees with information about the coronavirus pandemic through collaborations with international and national institutions.
  • View the full release here: https://www.businesswire.com/news/home/20200909005733/en/
    Hello Hope, a mobile application launched after the initial influx fleeing Syria by Turkcell, provides refugees with information about the coronavirus pandemic through collaborations with international and national institutions.
  • Hello Hope now further helps empowering Syrian refugees in Turkey during the coronavirus pandemic through collaborations with WHO, Turkish Red Crescent and Sesame Workshop.
  • Hello Hope app proves the power of mobile for integration as the app offers information delivered by Turkish Red Crescent and WHO in both Turkish and Arabic, directs users to Turkish Red Crescents website for further information, and offers cartoons produced by Sesame Workshop to refugee children.

Turkcell Launched Turkey’s Email Provider: YaaniMail

Retrieved on: 
Wednesday, December 25, 2019
Technology, VoIP, Other Technology, Telecommunications, Mobile, Wireless, Networks, Internet, Native American cuisine, Food and drink, North American cuisine, Poultry, Alfa Group, Turkcell, TKC, Domestic turkey, Tcell, Turkey

Turkcell (NYSE:TKC) (BIST:TCELL) today launched Turkeys email provider YaaniMail.

Key Points: 
  • Turkcell (NYSE:TKC) (BIST:TCELL) today launched Turkeys email provider YaaniMail.
  • YaaniMail offers users advanced security features and data generated on the platform is securely stored at Turkcells data centers.
  • View the full release here: https://www.businesswire.com/news/home/20191225005005/en/
    Turkcell today launched Turkeys email provider YaaniMail.
  • Emphasizing that Turkcell is embarked on creating Turkeys technologies, YaaniMail is part of a larger effort to ensure Turkeys data is hosted in Turkey.